Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

OvuSense - the certainty of ultrasound in a handheld monitor
  • USA - English


News provided by

Fertility Focus Ltd

Oct 17, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX


(PRWEB UK) 17 October 2013 -- A remarkable new technical development by a British medical company is set to have a major impact on the burgeoning cost of fertility treatment which is being met by public health services, insurance companies and individuals all over the world.

OvuSense is an advanced ovulation monitor that predicts the onset of ovulation, detects the exact ovulation date just three days after it occurs and provides all this information in real time on the screen to the user with an unprecedented 99% accuracy.

Post this

The developer is Fertility Focus Ltd, a company pioneering new technologies for fertility. The product is OvuSense - an advanced ovulation monitor that delivers an unprecedented 99% sensitivity and 99% accuracy. OvuSense predicts the onset of ovulation, detects the exact ovulation date just three days after it occurs, and provides all this information in real time on the screen to the user. This performance, for the first time, puts the certainty of ultrasound in a handheld ovulation monitor.

This certainty in ovulation detection also enables accurate prediction of the fertile window for each successive cycle. The fertile window is the period of 5-6 days in which it is possible for a woman to get pregnant, if egg and sperm are able to meet. This information is extremely valuable to women struggling to get pregnant because it helps with planning, and reassures them that they are getting on with the solution. It is equally valuable to clinicians committed to providing the best possible diagnosis and treatment pathway for their patients.

Many methods of predicting the fertile window have been developed and some are heavily marketed but, for a variety of reasons, all fall short of the accuracy and convenience provided by OvuSense.

Fertility Focus is a company with an interesting ability to adapt concepts from other fields into its chosen specialist area. The OvuSense story began at Bristol Veterinary School, one of the world’s leading animal science centres, where breakthroughs in bovine fertility research by two veterinary scientists led to the identification of the OvuSense concept for human fertility.

Full clinical trials in Birmingham, England have confirmed the scientific accuracy of the development by using direct comparison with ultrasound results and have created a stratified results database. This database also confirmed the variability and unpredictability of the fertile window and, with excellent trial results, Fertility Focus presented a poster on the first iteration of OvuSense at ASRM 2012.

Reproductive science supports the OvuSense approach. There is a body of peer-reviewed research which dispels the myth of the regular 28 day cycle. This is no more than a confusing ‘average’ relevant to less than 30% of the female population. In reality, the female cycle varies from as little as 21 days to as many as 35 and the timing of ovulation and the fertile window are rarely consistent within these different cycle lengths.

Determined to deliver even better quality information, Fertility Focus has undertaken further intensive R&D during 2013 which has led to the launch of the second generation OvuSense monitor just one year after launch. Work in 2013 has also resulted in two further clinical publications, one of which will be presented at this year’s ASRM, as well as the all-important 510(k) clearance allowing the product to be marketed in the United States.

CEO Robert Milnes describes the new development as “an incredibly exciting period in which we discovered trends in core temperature data which, because of our unique vaginal measurement technology, we believe we were the first people ever to see. These results enabled us to programme and patent a more advanced and more predictive algorithm using state-of-the-art techniques. Fertility Focus has chosen the most prestigious reproductive medicine conference, ASRM, combined this year with the IFFS meeting, to launch the second generation OvuSense.”

Ultrasound has emerged as the gold standard in the quest for understanding the fertile window, but it is only truly valuable if the scans are performed at the right time – and generally up to four scans are required per cycle, which presents an obstacle in terms of cost and patient convenience. OvuSense monitoring, combined with a single cycle scan for tracking the number of follicles, now offers a real practical alternative.

The emergence of OvuSense just eight years after the initial idea means that, with unexplained infertility rising as a percentage of all diagnoses, as many as 20% of the 150,000 IVF cycles undertaken annually in the USA and over 500,000 cycles in Europe might be avoided by providing a greater chance of conception earlier in the patient pathway.

---------- Ends ----------

Editor’s Notes – detailed notes available on request

For further information, contact Tim Mott – tma(at)fertility-focus(dot)com, +442088942288.

Tim Mott, Fertility Focus Ltd, http://www.fertility-focus.com, +44 2088942288, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.